Delving into the Latest Updates on QLF-31911 with Synapse

Overview

Basic Info

Drug Type

Monoclonal antibody

Synonyms

QLF 31911, QLF-31911, QLF31911

Target-

Action-

Mechanism-

Therapeutic Areas

Neoplasms

Active Indication-

Inactive Indication

Advanced cancer

Originator Organization

Qilu Pharmaceutical Co., Ltd.

Active Organization-

Inactive Organization

Qilu Pharmaceutical Co., Ltd.

License Organization-

Drug Highest PhaseSuspendedPhase 1

First Approval Date-

Regulation-

Login to view timeline

单药剂量递增主要研究目的：评价 QLF31911 单药在晚期恶性肿瘤患者中的安全性和耐受性，确定RP2D 。次要研究目的:观察 QLF31911 在晚期恶性肿瘤患者中静脉给药后的 PK特征；评价 QLF31911 在晚期恶性肿瘤患者中的免疫原性；评价 QLF31911 在晚期恶性肿瘤患者中的初步疗效。

[Translation]

Single-drug dose escalation The main study objectives are: to evaluate the safety and tolerability of QLF31911 monotherapy in patients with advanced malignant tumors and determine the RP2D. Secondary study objectives: to observe the PK characteristics of QLF31911 after intravenous administration in patients with advanced malignant tumors; to evaluate the immunogenicity of QLF31911 in patients with advanced malignant tumors; to evaluate the preliminary efficacy of QLF31911 in patients with advanced malignant tumors.

Start Date15 Feb 2022

Sponsor / Collaborator

Qilu Pharmaceutical Co., Ltd.

100 Clinical Results associated with QLF-31911

Login to view more data

100 Translational Medicine associated with QLF-31911

Login to view more data

100 Patents (Medical) associated with QLF-31911

Login to view more data

100 Deals associated with QLF-31911

Login to view more data

R&D Status

10 top R&D records.

Login

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Advanced cancer	Phase 1	China	Qilu Pharmaceutical Co., Ltd.	15 Feb 2022

Login to view more data

Clinical Result

Indication

Phase

Evaluation

View All Results

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.

login

or

view full example data

Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.

login

or

view full example data

Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.

login

or

view full example data

Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.

login

or

view full example data

Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.

login

or

view full example data

Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

login

or

view full example data